These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 18058538)
1. Telomere shortening in human HL60 cells by treatment with 3'-azido-2',3'-dideoxynucleosides and telomerase inhibition by their 5'-triphosphates. Liu X; Inomata M; Ogawara T; Saneyoshi M; Yamaguchi T Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1067-71. PubMed ID: 18058538 [TBL] [Abstract][Full Text] [Related]
2. Telomerase inhibition by 3'-azido-2', 3'-dideoxynucleoside 5'-triphosphates and telomere shortening in human cultured cells by the corresponding nucleosides. Yamaguchi T; Liu X; Ogawara T; Inomata M; Saneyoshi M Nucleic Acids Symp Ser (Oxf); 2006; (50):271-2. PubMed ID: 17150922 [TBL] [Abstract][Full Text] [Related]
3. 3'-Azido-2',3'-dideoxynucleoside 5'-triphosphates inhibit telomerase activity in vitro, and the corresponding nucleosides cause telomere shortening in human HL60 cells. Liu X; Takahashi H; Harada Y; Ogawara T; Ogimura Y; Mizushina Y; Saneyoshi M; Yamaguchi T Nucleic Acids Res; 2007; 35(21):7140-9. PubMed ID: 17942424 [TBL] [Abstract][Full Text] [Related]
4. Influence of 3'-azido-2',3'-dideoxyguanosine treatment on telomere length in human telomerase-immortalized human fibroblast cells. Kurashina Y; Liu X; Kato C; Inoue N; Saneyoshi M; Yamaguchi T Nucleic Acids Symp Ser (Oxf); 2009; (53):249-50. PubMed ID: 19749354 [TBL] [Abstract][Full Text] [Related]
5. Influence of nucleoside analogue treatment on telomere length and TRF2 amount in human HL60 cells. Liu X; Liu J; Ogawara T; Kurashina Y; Yashi R; Saneyoshi M; Yamaguchi T Nucleic Acids Symp Ser (Oxf); 2007; (51):253-4. PubMed ID: 18029682 [TBL] [Abstract][Full Text] [Related]
6. Synthetic nucleosides and nucleotides. 43. Inhibition of vertebrate telomerases by carbocyclic oxetanocin g (C.OXT-G) triphosphate analogues and influence of C.OXT-G treatment on telomere length in human HL60 cells. Yamaguchi T; Saneyoshi M; Takahashi H; Hirokawa S; Amano R; Liu X; Inomata M; Maruyama T Nucleosides Nucleotides Nucleic Acids; 2006; 25(4-6):539-51. PubMed ID: 16838844 [TBL] [Abstract][Full Text] [Related]
7. Influence of 3'-azido-2',3'-dideoxyguanosine treatment on amounts of TERT and POT1 in human HL60 cells. Liu X; Ogawara T; Kurashina Y; Saneyoshi M; Yamaguchi T Nucleic Acids Symp Ser (Oxf); 2008; (52):491-2. PubMed ID: 18776468 [TBL] [Abstract][Full Text] [Related]
8. Telomere shortening in human HL60 cells by treatment with deoxyguanosine analogs. Yamaguchi T; Takahashi H; Harada Y; Yoshikawa M; Iyono S; Inomata M; Maruyama T; Saneyoshi M Nucleic Acids Symp Ser (Oxf); 2004; (48):187-8. PubMed ID: 17150541 [TBL] [Abstract][Full Text] [Related]
9. Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells. Binz N; Shalaby T; Rivera P; Shin-ya K; Grotzer MA Eur J Cancer; 2005 Dec; 41(18):2873-81. PubMed ID: 16253503 [TBL] [Abstract][Full Text] [Related]
10. [Inhibition of HIV reproduction in cell culture by 5'-phosphonates of 3'-azido-2',3'-dideoxynucleosides]. Tarusova NB; Khorlin AA; Kraevskiĭ AA; Korneeva MN; Nosik DN; Kruglov IV; Galegov GA; Bibilashvili RSh Mol Biol (Mosk); 1989; 23(6):1716-24. PubMed ID: 2633042 [TBL] [Abstract][Full Text] [Related]
11. Influence of long-term treatment with cytosine arabinoside on telomere length in human HL60 cells. Yamaguchi T; Kazama K; Takashima J; Ogawara T; Iyono S; Inomata M; Saneyoshi M Nucleic Acids Symp Ser (Oxf); 2005; (49):289-90. PubMed ID: 17150747 [TBL] [Abstract][Full Text] [Related]
12. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Strahl C; Blackburn EH Mol Cell Biol; 1996 Jan; 16(1):53-65. PubMed ID: 8524329 [TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of telomerase inhibitor TMPyP4 in osteosarcoma cell lines. Fujimori J; Matsuo T; Shimose S; Kubo T; Ishikawa M; Yasunaga Y; Ochi M J Orthop Res; 2011 Nov; 29(11):1707-11. PubMed ID: 21590716 [TBL] [Abstract][Full Text] [Related]
14. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase. Gomez D; Aouali N; Renaud A; Douarre C; Shin-Ya K; Tazi J; Martinez S; Trentesaux C; Morjani H; Riou JF Cancer Res; 2003 Oct; 63(19):6149-53. PubMed ID: 14559794 [TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis and inhibition of telomerase activity in human bone marrow and HL-60 p53 null cells treated with anti-cancer drugs. Malerba I; Gribaldo L; Diodovich C; Carloni M; Meschini R; Bowe G; Collotta A Toxicol In Vitro; 2005 Jun; 19(4):523-32. PubMed ID: 15826810 [TBL] [Abstract][Full Text] [Related]
16. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach. Mo Y; Gan Y; Song S; Johnston J; Xiao X; Wientjes MG; Au JL Cancer Res; 2003 Feb; 63(3):579-85. PubMed ID: 12566299 [TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein-7 inhibits telomerase activity, telomere maintenance, and cervical tumor growth. Cassar L; Li H; Pinto AR; Nicholls C; Bayne S; Liu JP Cancer Res; 2008 Nov; 68(22):9157-66. PubMed ID: 19010887 [TBL] [Abstract][Full Text] [Related]
18. Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells. Liu WJ; Zhang YW; Shen Y; Jiang JF; Miao ZH; Ding J Biochem Biophys Res Commun; 2004 Oct; 323(2):660-7. PubMed ID: 15369801 [TBL] [Abstract][Full Text] [Related]
19. [Progress in telomerase and the inhibitors]. Zhou Y; Gong XG Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):604-7. PubMed ID: 11910748 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease. Tárkányi I; Aradi J Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]